Stock page

Bio-Rad Laboratories Inc (BIO.B)

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Quote snapshot

$255.54
Daily change: —
ExchangeNYSE
Updated2026-05-09T03:36:38.411578Z

Price chart

Price history

Name
Revenue
Cost Of Goods Sold
Gross Profit
Gross Margin %
Research Development
Selling General Admin Expense
Depreciation Depletion Amortization
Other Operating Expense
Total Operating Expense
Operating Income
Operating Margin
Interest Income
Interest Expense
Other Income Expense
Other Income Minority Interest
Other Net Income Loss
Ebit
Ebitda
Ebitda Margin
Pretax Income
Tax Provision
Tax Rate
Net Income Continuing Operations
Net Income Discontinued Operations
Net Income
Net Income Including Noncontrolling Interests
Is Preferred Dividends
Shares Outstanding
Eps Basic
Eps Diluted
Net Margin

SEC filings

Latest 10-K filing table

Date Form Accession Link